G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,055,434 | -7.1% | 423,869 | 0.0% | 0.04% | -4.7% |
| Q1 2023 | $1,135,969 | -50.6% | 423,869 | 0.0% | 0.04% | -50.6% |
| Q4 2022 | $2,301,609 | -56.5% | 423,869 | 0.0% | 0.09% | -59.9% |
| Q3 2022 | $5,294,000 | +152.8% | 423,869 | 0.0% | 0.22% | +164.6% |
| Q2 2022 | $2,094,000 | -35.0% | 423,869 | 0.0% | 0.08% | -27.4% |
| Q1 2022 | $3,221,000 | -25.6% | 423,869 | 0.0% | 0.11% | -18.7% |
| Q4 2021 | $4,328,000 | -48.3% | 423,869 | -32.1% | 0.14% | -48.5% |
| Q3 2021 | $8,379,000 | -38.8% | 624,369 | 0.0% | 0.27% | -39.3% |
| Q2 2021 | $13,699,000 | +45.3% | 624,369 | +59.4% | 0.44% | +37.3% |
| Q1 2021 | $9,426,000 | – | 391,754 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |